Westpac Banking Corp Makes New Investment in Danaher Corporation $DHR

Westpac Banking Corp acquired a new stake in Danaher Corporation (NYSE:DHRFree Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 6,981 shares of the conglomerate’s stock, valued at approximately $1,330,000.

A number of other hedge funds also recently made changes to their positions in the business. High Note Wealth LLC increased its holdings in shares of Danaher by 19.2% during the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after acquiring an additional 47 shares during the last quarter. First Command Advisory Services Inc. lifted its holdings in Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after purchasing an additional 47 shares during the last quarter. GW&K Investment Management LLC lifted its holdings in Danaher by 8.4% during the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after purchasing an additional 47 shares during the last quarter. Kestra Private Wealth Services LLC boosted its position in Danaher by 0.3% during the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after purchasing an additional 48 shares during the period. Finally, SOL Capital Management CO boosted its position in Danaher by 2.7% during the fourth quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock worth $430,000 after purchasing an additional 50 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

DHR has been the topic of several research analyst reports. Royal Bank Of Canada increased their price objective on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. Citigroup assumed coverage on shares of Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price for the company. Guggenheim decreased their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. Finally, Evercore restated an “outperform” rating and set a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Get Our Latest Analysis on Danaher

Danaher Stock Up 1.6%

DHR stock opened at $219.42 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock has a market capitalization of $154.25 billion, a price-to-earnings ratio of 38.97, a PEG ratio of 2.72 and a beta of 0.78. The business’s fifty day moving average price is $195.80 and its two-hundred day moving average price is $192.61. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHRGet Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the previous year, the business posted $0.77 earnings per share. Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. On average, equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.